Carbatol 200mg, containing the active ingredient Carbamazepine, is a cornerstone in the treatment of epilepsy and trigeminal neuralgia. This medication is designed to stabilize neural membranes and prevent the spread of seizure activity while also providing relief from the intense pain associated with trigeminal neuralgia. As an extended-release formulation, Carbatol ensures consistent blood levels of Carbamazepine, enhancing patient compliance with a once-daily dosing regimen.
- Extended-Release Formulation: Provides steady-state plasma levels for 24-hour seizure control with a convenient once-daily dose.
- Dual Action: Effective in managing both epilepsy and trigeminal neuralgia, making it a versatile choice for neurological conditions.
- Safety Profile: Carbatol has a well-established safety and efficacy profile, with precautions for use in patients with certain medical conditions and interactions with other medications.
Usage and Precautions:
Carbatol is indicated for adults and should be used under the guidance of a healthcare professional. Patients with a history of bone marrow depression, hypersensitivity to tricyclic compounds, or those taking monoamine oxidase inhibitors should avoid this medication. Special caution is advised for patients with hepatic or renal impairment and those with heart conditions.
For the best outcome, Carbatol should be taken with meals to minimize gastrointestinal discomfort and ensure optimal absorption. The dosing may be adjusted based on clinical response and tolerability, under the supervision of a healthcare provider.